Form 8-K - Current report:
SEC Accession No. 0001615219-18-000049
Filing Date
2018-08-01
Accepted
2018-08-01 08:10:27
Documents
2
Period of Report
2018-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks201806308-k.htm 8-K 25713
2 EXHIBIT 99.1 flks201806308-kpr991.htm EX-99.1 100606
  Complete submission text file 0001615219-18-000049.txt   127445
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 18983094
SIC: 2834 Pharmaceutical Preparations